Apelin secretion and expression of apelin receptors in 3T3-L1 adipocytes are differentially regulated by angiotensin type 1 and type 2 receptors

Molecular and Cellular Endocrinology

Volumn 351, Issue 2, 2012, Pages 296-305

  Than, Aung ^a   Tee, Wei Teng ^a   Chen, Peng ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Angiotensin II; Angiotensin receptors; Apelin; Apelin receptor

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; APELIN; APELIN RECEPTOR; CALCIUM ION; CYCLIC AMP; CYCLIC GMP; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME IMMUNOASSAY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPOCYTES; ANGIOTENSIN II; ANIMALS; CALCIUM; CELL LINE; CYCLIC AMP; CYCLIC GMP; FLAVONOIDS; GENE EXPRESSION REGULATION; IMIDAZOLES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NAPHTHYRIDINES; PROTEIN KINASE C; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84863419726     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.01.005     Document Type: Article

References (85)

1. Alastalo T.P., Li M., Perez Vde J., Pham D., Sawada H., Wang J.K., Koskenvuo M., Wang L., Freeman B.A., Chang H.Y., Rabinovitch M. Disruption of PPARgamma/beta-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival. Journal of Clinical Investigation 2011, 121:3735-3746.
2. Aneja A., El-Atat F., McFarlane S.I., Sowers J.R. Hypertension and obesity. Recent Progress in Hormone Research 2004, 59:169-205.
3. Ashley E.A., Powers J., Chen M., Kundu R., Finsterbach T., Caffarelli A., Deng A., Eichhorn J., Mahajan R., Agrawal R., Greve J., Robbins R., Patterson A.J., Bernstein D., Quertermous T. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovascular Research 2005, 65:73-82.
4. Attane C., Daviaud D., Dray C., Dusaulcy R., Masseboeuf M., Prevot D., Carpene C., Castan-Laurell I., Valet P. Apelin stimulates glucose uptake but not lipolysis in human adipose tissue ex vivo. Journal of Molecular Endocrinology 2010, 46:21-28.
5. Blankley C.J., Hodges J.C., Klutchko S.R., Himmelsbach R.J., Chucholowski A., Connolly C.J., Neergaard S.J., Van Nieuwenhze M.S., Sebastian A., Quin J., et al. Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype. Journal of Medicinal Chemistry 1991, 34:3248-3260.
6. Boucher J., Masri B., Daviaud D., Gesta S., Guigne C., Mazzucotelli A., Castan-Laurell I., Tack I., Knibiehler B., Carpene C., Audigier Y., Saulnier-Blache J.S., Valet P. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005, 146:1764-1771.
7. Castan-Laurell I., Vitkova M., Daviaud D., Dray C., Kovacikova M., Kovacova Z., Hejnova J., Stich V., Valet P. Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ. European Journal of Endocrinology/European Federation of Endocrine Societies 2008, 158:905-910.
8. Chen M.M., Ashley E.A., Deng D.X., Tsalenko A., Deng A., Tabibiazar R., Ben-Dor A., Fenster B., Yang E., King J.Y., Fowler M., Robbins R., Johnson F.L., Bruhn L., McDonagh T., Dargie H., Yakhini Z., Tsao P.S., Quertermous T. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 2003, 108:1432-1439.
9. Chen P., Gillis K.D. The noise of membrane capacitance measurements in the whole-cell recording configuration. Biophysical Journal 2000, 79:2162-2170.
10. Chen P., Hwang T.C., Gillis K.D. The relationship between cAMP, Ca(2)+, and transport of CFTR to the plasma membrane. Journal of General Physiology 2001, 118:135-144.
11. Chung O., Stoll M., Unger T. Physiologic and pharmacologic implications of AT1 versus AT2 receptors. Blood Press Supplementary 1996, 2:47-52.
12. Cox B.E., Rosenfeld C.R. Ontogeny of vascular angiotensin II receptor subtype expression in ovine development. Pediatric Research 1999, 45:414-424.
13. de Gasparo M., Catt K.J., Inagami T., Wright J.W., Unger T. International union of pharmacology. XXIII: the angiotensin II receptors. Pharmacological Reviews 2000, 52:415-472.
14. Di Filippo C., Lampa E., Tufariello E., Petronella P., Freda F., Capuano A., D'Amico M. Effects of irbesartan on the growth and differentiation of adipocytes in obese zucker rats. Obesity Research 2005, 13:1909-1914.
15. Dinh D.T., Frauman A.G., Johnston C.I., Fabiani M.E. Angiotensin receptors: distribution, signalling and function. Clinical Science (London) 2001, 100:481-492.
16. Dray C., Knauf C., Daviaud D., Waget A., Boucher J., Buleon M., Cani P.D., Attane C., Guigne C., Carpene C., Burcelin R., Castan-Laurell I., Valet P. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metabolism 2008, 8:437-445.
17. Engeli S., Gorzelniak K., Kreutz R., Runkel N., Distler A., Sharma A.M. Co-expression of renin-angiotensin system genes in human adipose tissue. Journal of Hypertension 1999, 17:555-560.
18. Engeli S., Schling P., Gorzelniak K., Boschmann M., Janke J., Ailhaud G., Teboul M., Massiera F., Sharma A.M. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?. International Journal of Biochemistry and Cell Biology 2003, 35:807-825.
19. Fricke K., Heitland A., Maronde E. Cooperative activation of lipolysis by protein kinase A and protein kinase C pathways in 3T3-L1 adipocytes. Endocrinology 2004, 145:4940-4947.
20. Fruhbeck G., Gomez-Ambrosi J., Muruzabal F.J., Burrell M.A. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. American Journal of Physiology, Endocrinology and Metabolism 2001, 280:E827-E847.
21. Goossens G.H., Blaak E.E., Arner P., Saris W.H., van Baak M.A. Angiotensin II: a hormone that affects lipid metabolism in adipose tissue. International Journal of Obesity (London) 2007, 31:382-384.
22. Goossens G.H., Blaak E.E., van Baak M.A. Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders. Obesity Reviews 2003, 4:43-55.
23. Gorzelniak K., Engeli S., Janke J., Luft F.C., Sharma A.M. Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension. Journal of Hypertension 2002, 20:965-973.
24. Griendling K.K., Lassegue B., Alexander R.W. Angiotensin receptors and their therapeutic implications. Annual Review of Pharmacology and Toxicology 1996, 36:281-306.
25. Hansen J.L., Servant G., Baranski T.J., Fujita T., Iiri T., Sheikh S.P. Functional reconstitution of the angiotensin II type 2 receptor and G(i) activation. Circulation Research 2000, 87:753-759.
26. He H., Yang D., Ma L., Luo Z., Ma S., Feng X., Cao T., Yan Z., Liu D., Tepel M., Zhu Z. Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-delta-dependent pathways. Hypertension 2010, 55:869-879.
27. Higuchi K., Masaki T., Gotoh K., Chiba S., Katsuragi I., Tanaka K., Kakuma T., Yoshimatsu H. Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. Endocrinology 2007, 148:2690-2697.
28. Hung W.W., Hsieh T.J., Lin T., Chou P.C., Hsiao P.J., Lin K.D., Shin S.J. Blockade of the Renin-Angiotensin System Ameliorates Apelin Production in 3T3-L1 Adipocytes. Cardiovascular Drugs Theraphy 2010, 25:3-12.
29. Iwanaga Y., Kihara Y., Takenaka H., Kita T. Down-regulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin II-angiotensin type 1 receptor system. Journal of Molecular and Cellular Cardiology 2006, 41:798-806.
30. Jia Y.X., Lu Z.F., Zhang J., Pan C.S., Yang J.H., Zhao J., Yu F., Duan X.H., Tang C.S., Qi Y.F. Apelin activates l-arginine/nitric oxide synthase/nitric oxide pathway in rat aortas. Peptides 2007, 28:2023-2029.
31. Jin X.H., Wang Z.Q., Siragy H.M., Guerrant R.L., Carey R.M. Regulation of jejunal sodium and water absorption by angiotensin subtype receptors. American Journal of Physiology 1998, 275:R515-R523.
32. Johren O., Dendorfer A., Dominiak P. Cardiovascular and renal function of angiotensin II type-2 receptors. Cardiovascular Research 2004, 62:460-467.
33. Jones B.H., Standridge M.K., Moustaid N. Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology 1997, 138:1512-1519.
34. Juan C.C., Chien Y., Wu L.Y., Yang W.M., Chang C.L., Lai Y.H., Ho P.H., Kwok C.F., Ho L.T. Angiotensin II enhances insulin sensitivity in vitro and in vivo. Endocrinology 2005, 146:2246-2254.
35. Kakuma T. Telmisartan reduced abdominal circumference and body weight with decreasing triglyceride level in patients with type 2 diabetes and metabolic syndrome. Obesity Research and Clinical Practice 2009, 4:e145-e152.
36. Karastergiou K., Mohamed-Ali V. The autocrine and paracrine roles of adipokines. Molecular and Cellular Endocrinology 2010, 318:69-78.
37. Kaschina E., Unger T. Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Pressure 2003, 12:70-88.
38. Kim S., Whelan J., Claycombe K., Reath D.B., Moustaid-Moussa N. Angiotensin II increases leptin secretion by 3T3-L1 and human adipocytes via a prostaglandin-independent mechanism. Journal of Nutrition 2002, 132:1135-1140.
39. Kleinz M.J., Davenport A.P. Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regulatory Peptides 2004, 118:119-125.
40. Kotsis V., Stabouli S., Papakatsika S., Rizos Z., Parati G. Mechanisms of obesity-induced hypertension. Hypertension Research: Official Journal of the Japanese Society of Hypertension 2010, 33:386-393.
41. Kramer B.K., Ritthaler T., Schweda F., Ittner K.P., Scholz H., Riegger G.A., Kurtz A. Effects of the angiotensin II type-1 receptor antagonist ZD7155 on angiotensin II-mediated regulation of renin secretion and renal renin gene expression, renal vasoconstriction, and blood pressure in rats. Journal of Cardiovascular Pharmacology 1998, 31:700-705.
42. Kunduzova O., Alet N., Delesque-Touchard N., Millet L., Castan-Laurell I., Muller C., Dray C., Schaeffer P., Herault J.P., Savi P., Bono F., Valet P. Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes. FASEB Journal 2008, 22:4146-4153.
43. Lago F., Gomez R., Gomez-Reino J.J., Dieguez C., Gualillo O. Adipokines as novel modulators of lipid metabolism. Trends in Biochemical Sciences 2009, 34:500-510.
44. Lee D.K., Saldivia V.R., Nguyen T., Cheng R., George S.R., O'Dowd B.F. Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. Endocrinology 2005, 146:231-236.
45. Lemarie, C.A., Schiffrin, E.L., 2010. The angiotensin II type 2 receptor in cardiovascular disease. Journal of the Renin-Angiotensin-Aldosterone System: JRAAS 11, 19-31.
46. Lucius R., Gallinat S., Busche S., Rosenstiel P., Unger T. Beyond blood pressure: new roles for angiotensin II. Cellular and Molecular Life Sciences 1999, 56:1008-1019.
47. Mallow H., Trindl A., Loffler G. Production of angiotensin II receptors type one (AT1) and type two (AT2) during the differentiation of 3T3-L1 preadipocytes. Hormone and Metabolic Research 2000, 32:500-503.
48. Matsushita K., Wu Y., Okamoto Y., Pratt R.E., Dzau V.J. Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes. Hypertension 2006, 48:1095-1102.
49. Matsuzawa Y. The metabolic syndrome and adipocytokines. Expert Review of Clinical Immunology 2007, 3:39-46.
50. Mazzucotelli A., Ribet C., Castan-Laurell I., Daviaud D., Guigne C., Langin D., Valet P. The transcriptional co-activator PGC-1alpha up regulates apelin in human and mouse adipocytes. Regulatory Peptides 2008, 150:33-37.
51. McMullen J.R., Gibson K.J., Lumbers E.R., Burrell J.H. 125I[Sar(1)Ile(8)] angiotensin II has a different affinity for AT(1) and AT(2) receptor subtypes in ovine tissues. Regulatory Peptides 2002, 105:83-92.
52. Morgan A., Burgoyne R.D., Barclay J.W., Craig T.J., Prescott G.R., Ciufo L.F., Evans G.J., Graham M.E. Regulation of exocytosis by protein kinase C. Biochemical Society Transactions 2005, 33:1341-1344.
53. Mori Y., Itoh Y., Tajima N. Angiotensin II receptor blockers downsize adipocytes in spontaneously type 2 diabetic rats with visceral fat obesity. American Journal of Hypertension 2007, 20:431-436.
54. Munoz M.C., Giani J.F., Dominici F.P., Turyn D., Toblli J.E. Long-term treatment with an angiotensin II receptor blocker decreases adipocyte size and improves insulin signaling in obese Zucker rats. Journal of Hypertension 2009, 27:2409-2420.
55. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nature Reviews Immunology 2011, 11:85-97.
56. Ranganathan G., Song W., Dean N., Monia B., Barger S.W., Kern P.A. Regulation of lipoprotein lipase by protein kinase C alpha in 3T3-F442A adipocytes. Journal of Biological Chemistry 2002, 277:38669-38675.
57. Rayalam S., Della-Fera M.A., Krieg P.A., Cox C.M., Robins A., Baile C.A. A putative role for apelin in the etiology of obesity. Biochemical and Biophysical Research Communications 2008, 368:815-819.
58. Reaux A., De Mota N., Skultetyova I., Lenkei Z., El Messari S., Gallatz K., Corvol P., Palkovits M., Llorens-Cortes C. Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. Journal of Neurochemistry 2001, 77:1085-1096.
59. Rupnick M.A., Panigrahy D., Zhang C.Y., Dallabrida S.M., Lowell B.B., Langer R., Folkman M.J. Adipose tissue mass can be regulated through the vasculature. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:10730-10735.
60. Sarzani R., Marcucci P., Salvi F., Bordicchia M., Espinosa E., Mucci L., Lorenzetti B., Minardi D., Muzzonigro G., Dessi-Fulgheri P., Rappelli A. Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth. International Journal of Obesity 2008, 32:259-267.
61. Schieffer B., Paxton W.G., Marrero M.B., Bernstein K.E. Importance of tyrosine phosphorylation in angiotensin II type 1 receptor signaling. Hypertension 1996, 27:476-480.
62. Schling P. Expression of angiotensin II receptors type 1 and type 2 in human preadipose cells during differentiation. Hormone and Metabolic Research 2002, 34:709-715.
63. Schling P., Loffler G. Cross talk between adipose tissue cells: impact on pathophysiology. News Physiological Science 2002, 17:99-104.
64. Simons P.J., van den Pangaart P.S., Aerts J.M., Boon L. Pro-inflammatory delipidizing cytokines reduce adiponectin secretion from human adipocytes without affecting adiponectin oligomerization. Journal of Endocrinology 2007, 192:289-299.
65. Skurk T., Lee Y.M., Hauner H. Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture. Hypertension 2001, 37:1336-1340.
66. Skurk T., van Harmelen V., Hauner H. Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-kappaB. Arteriosclerosis, Thrombosis, and Vascular Biology 2004, 24:1199-1203.
67. Soo J.C., Zhang J., He Q., Agarwal S., Li H., Zhang H., Chen P. Surface immobilized cholera toxin B subunit (CTB) facilitates vesicle docking, trafficking and exocytosis. Integrative Biology 2010, 2:250-257.
68. Sumners C., Tang W., Zelezna B., Raizada M.K. Angiotensin II receptor subtypes are coupled with distinct signal-transduction mechanisms in neurons and astrocytes from rat brain. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:7567-7571.
69. Takekoshi K., Ishii K., Shibuya S., Kawakami Y., Isobe K., Nakai T. Angiotensin II type 2 receptor counter-regulates type 1 receptor in catecholamine synthesis in cultured porcine adrenal medullary chromaffin cells. Hypertension 2002, 39:142-148.
70. Than, A., Tan, Y., Ong, W.Y., Farooqui, A.A., Chen, P., 2011b. Kainate Receptors Mediate Regulated Exocytosis of Secretory Phospholipase A(2) in SH-SY5Y Neuroblastoma Cells. Neuro-Signals, doi: 10.1159/000330414.
71. Than A., Ye F., Xue R., Ong J.W., Poh C.L., Chen P. The crosstalks between adipokines and catecholamines. Molecular and Cellular Endocrinology 2011, 332:261-270.
72. Utsugisawa K., Kizawa H., Nagane Y., Kondoh R., Iwa Y., Akutsu H., Tohgi H., Terayama Y. Biphasic effects of angiotensin II and receptor antagonism on aggregability and protein kinase C phosphorylation in human platelets. Thrombosis and Haemostasis 2005, 94:1012-1018.
73. Valle A., Hoggard N., Adams A.C., Roca P., Speakman J.R. Chronic central administration of apelin-13 over 10 days increases food intake, body weight, locomotor activity and body temperature in C57BL/6 mice. Journal of Neuroendocrinology 2008, 20:79-84.
74. Wei L., Hou X., Tatemoto K. Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes. Regulatory Peptides 2005, 132:27-32.
75. Weiland F., Verspohl E.J. Variety of angiotensin receptors in 3T3-L1 preadipose cells and differentiated adipocytes. Hormone and Metabolic Research 2008, 40:760-766.
76. Williams D.A., Fay F.S. Intracellular calibration of the fluorescent calcium indicator Fura-2. Cell Calcium 1990, 11:75-83.
77. Xie H., Tang S.Y., Cui R.R., Huang J., Ren X.H., Yuan L.Q., Lu Y., Yang M., Zhou H.D., Wu X.P., Luo X.H., Liao E.Y. Apelin and its receptor are expressed in human osteoblasts. Regulatory Peptides 2006, 134:118-125.
78. Xie L., O'Reilly C.P., Chapes S.K., Mora S. Adiponectin and leptin are secreted through distinct trafficking pathways in adipocytes. Biochimica et Biophysica Acta 2008, 1782:99-108.
79. Xue R., Zhao Y., Chen P. Involvement of PKC alpha in PMA-induced facilitation of exocytosis and vesicle fusion in PC12 cells. Biochemical and Biophysical Research Communications 2009, 380:371-376.
80. Ye F., Than A., Zhao Y., Goh K.H., Chen P. Vesicular storage, vesicle trafficking, and secretion of leptin and resistin: the similarities, differences, and interplays. Journal of Endocrinology 2010, 206:27-36.
81. Yue P., Jin H., Aillaud M., Deng A.C., Azuma J., Asagami T., Kundu R.K., Reaven G.M., Quertermous T., Tsao P.S. Apelin is necessary for the maintenance of insulin sensitivity. American Journal of Physiology, Endocrinology and Metabolism 2010, 298:E59-E67.
82. Yue P., Jin H., Xu S., Aillaud M., Deng A.C., Azuma J., Kundu R.K., Reaven G.M., Quertermous T., Tsao P.S. Apelin decreases lipolysis via G(q), G(i), and AMPK-dependent mechanisms. Endocrinology 2011, 152:59-68.
83. Zhang J., Pratt R.E. The AT2 receptor selectively associates with Gialpha2 and Gialpha3 in the rat fetus. Journal of Biological Chemistry 1996, 271:15026-15033.
84. Zhang J., Xue R., Ong W.Y., Chen P. Roles of cholesterol in vesicle fusion and motion. Biophysical Journal 2009, 97:1371-1380.
85. Zheng Y., Horita S., Hara C., Kunimi M., Yamada H., Sugaya T., Goto A., Fujita T., Seki G. Biphasic regulation of renal proximal bicarbonate absorption by luminal AT(1A) receptor. Journal of the American Society Nephrology 2003, 14:1116-1122.